Azenta (AZTA) Stock Price, News & Analysis

+1.25 (+2.46%)
(As of 09:52 AM ET)
Today's Range
50-Day Range
52-Week Range
21,002 shs
Average Volume
422,662 shs
Market Capitalization
$2.91 billion
P/E Ratio
Dividend Yield
Price Target

Azenta MarketRank™ Stock Analysis

Analyst Rating
2.33 Rating Score
34.6% Upside
$69.60 Price Target
Short Interest
7.61% of Float Sold Short
Dividend Strength
News Sentiment
1.61mentions of Azenta in the last 14 days
Based on 2 Articles This Week
Insider Trading
Proj. Earnings Growth
From $0.27 to $0.50 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.15 out of 5 stars

Medical Sector

325th out of 910 stocks

Special Industry Machinery, Not Elsewhere Classified Industry

7th out of 13 stocks

AZTA stock logo

About Azenta Stock (NASDAQ:AZTA)

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

AZTA Stock Price History

AZTA Stock News Headlines

Azenta is Now Oversold (AZTA)
I have a unique way to “hijack” the stock market.
I have a unique way to “hijack” the stock market. And it’s not a matter of picking the next, big Amazon-like stock… Or guessing on the next A.I. moonshot like NVDA… This is not as hard as making amazing predictions like those.
Decoding 7 Analyst Evaluations For Azenta
I have a unique way to “hijack” the stock market.
I have a unique way to “hijack” the stock market. And it’s not a matter of picking the next, big Amazon-like stock… Or guessing on the next A.I. moonshot like NVDA… This is not as hard as making amazing predictions like those.
In-Depth Examination Of 5 Analyst Recommendations For Azenta
Strong Buy Rating for Azenta, Inc. Amid Growth and Strategic Initiatives
Azenta: Q1 Earnings Insights
Preview: Azenta's Earnings
Natural gas utility Spire names new chairman
Azenta to Host Investor Day on March 14, 2024
See More Headlines
Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Special industry machinery, not elsewhere classified
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
6 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$641.02 million
Cash Flow
$1.64 per share
Book Value
$42.10 per share


Free Float
Market Cap
$2.84 billion
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Dr. Stephen S. Schwartz (Age 65)
    CEO, President & Director
    Comp: $1.05M
  • Mr. Robin Vacha (Age 48)
    Senior Vice President of Global Operations
    Comp: $533.35k
  • Mr. Jason W. Joseph (Age 53)
    Senior VP, General Counsel & Corporate Secretary
    Comp: $544.13k
  • Mr. Herman Cueto (Age 50)
    Executive VP & CFO
  • Ms. Violetta Hughes (Age 52)
    VP & Chief Accounting Officer
  • Mr. Michael Paulo
    VP and Chief Information & Digital Officer
  • Mr. John E. O'Brien (Age 54)
    Senior Vice President of Corporate Development
  • Ms. Olga Pirogova (Age 50)
    Senior VP & Chief HR Officer
  • Mr. J. Robert Woodward
    Senior Vice President of Global Quality & Regulatory
  • Dr. Ginger Zhou Ph.D. (Age 47)
    Senior VP & GM of Multiomics and Synthesis Solutions

AZTA Stock Analysis - Frequently Asked Questions

Should I buy or sell Azenta stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Azenta in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AZTA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AZTA, but not buy additional shares or sell existing shares.
View AZTA analyst ratings
or view top-rated stocks.

What is Azenta's stock price target for 2024?

6 equities research analysts have issued 1 year target prices for Azenta's shares. Their AZTA share price targets range from $60.00 to $79.00. On average, they anticipate the company's stock price to reach $69.60 in the next year. This suggests a possible upside of 34.6% from the stock's current price.
View analysts price targets for AZTA
or view top-rated stocks among Wall Street analysts.

How have AZTA shares performed in 2024?

Azenta's stock was trading at $65.14 at the start of the year. Since then, AZTA stock has decreased by 20.6% and is now trading at $51.69.
View the best growth stocks for 2024 here

When is Azenta's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our AZTA earnings forecast

How were Azenta's earnings last quarter?

Azenta, Inc. (NASDAQ:AZTA) announced its quarterly earnings data on Wednesday, February, 7th. The company reported $0.02 EPS for the quarter. The firm earned $154.32 million during the quarter, compared to analysts' expectations of $151.86 million. Azenta had a negative net margin of 2.92% and a positive trailing twelve-month return on equity of 0.49%.

What guidance has Azenta issued on next quarter's earnings?

Azenta issued an update on its FY 2024 earnings guidance on Thursday, March, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $696.0 million-$718.0 million, compared to the consensus revenue estimate of $703.6 million.

Who are Azenta's major shareholders?

Azenta's stock is owned by a number of institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (1.90%), Raymond James & Associates (0.20%), Norden Group LLC (0.05%), State of Michigan Retirement System (0.02%), Park Avenue Securities LLC (0.02%) and State of Alaska Department of Revenue (0.01%). Insiders that own company stock include David C Gray, Jesus Linda De, Kimberly Crowley, Lindon G Robertson and Matthew Mcmanus.
View institutional ownership trends

How do I buy shares of Azenta?

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AZTA) was last updated on 4/23/2024 by Staff

From Our Partners